CROMBEZ ERIC (EVP and Chief Medical Officer) sold 0.3% of their position (344.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $8.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/6/2026ACC: 0001193125-26-208632
Officer· EVP and Chief Medical Officer
Since Mar 2026
-344.00
Net shares
Net seller
$8.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
344.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−344.00
Price / share
$24.96
Trade value
$8.59K
% of position
0.3%
5/5/2026
111.53K→111.19K
Total
Net shares
−344.00
Net value
-$8.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | S · Sale | −344.00 | $24.96 | $8.59K | 0.3% | 111.53K | 111.19K |
| Total | −344.00 | -$8.59K | ||||||
Derivative Transactions0
No derivative transactions reported